Custom machine kept man alive without lungs for 48 hours

For two days, the patient lived as a human being with no lungs, stabilized by a machine that breathed and buffered his ...
ScienceAlert on MSN

Surgeons kept a man alive with no lungs for 48 hours. Here's how.

In a remarkable act of life preservation, surgeons were able to keep a critically ill man alive for 48 hours without a pair ...
Gadget Review on MSN

How Surgeons Used "Breast Implants" to Keep a Heart Beating Without Lungs for 48 Hours

Northwestern Medicine surgeons kept a 33-year-old man alive for 48 hours without lungs using a Total Artificial Lung system ...
WHYY

A Philadelphia surgeon’s invention and historic open-heart operation is celebrated 70 years later

Dr. John Gibbon invented the heart-lung machine and used it to perform the world’s first successful open-heart surgery on May 6, 1953. Dr. John Gibbon was a researcher and surgeon at Jefferson Medical ...
Dagens.com on MSN

Two days without lungs: How doctors pulled off a miracle

Sometimes, a simple illness can become life-threatening in ways most people cannot imagine.
Business Insider

The Global Heart-lung Machines Market is expected to grow by $ 40.13 mn during 2020-2024, progressing at a CAGR of 3% during the forecast period

New York, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Heart-lung Machines Market 2020-2024" - https://www ...
Business Wire

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
Healio

FDA designates recall of heart-lung machine emergency drive as class I

Please provide your email address to receive an email when new articles are posted on . The FDA designated the recall of Getinge’s heart-lung machine emergency drive as class I, the most serious type.